| Joel Farley |
Joel
F.
Farley
PhD
Assistant Professor |
Office |
Phone
Email |
1. Farley JF, Devine JD, Hadsall RS. (2007) “Professional implications of the expansion of pharmacy-based medical clinics”. Journal of the American Pharmacists Association 47(3): 410-413.
2. Lu YJ, Farley JF, Hansen RA. (2006) “Promotion and market share in the proton pump inhibitor market: A case study”. The Journal of Pharmaceutical Marketing and Management. 17(3/4): 39-59.
3. Farley JF, Cline RR, Gupta K. (2006) “Racial variation in antiresorptive medications use: results from the 2000 Medical Expenditure Panel Survey (MEPS)”. Osteoporosis International. 17(3): 395-404.
4. Devine JW, Cline RR, Farley JF. (2006) “What is the benefit of a market without generic biologics? the uncertain future of generic competition in the biopharmaceutical market.” Journal of the American Pharmacists Association. 46(2): 193-201.
5. Farley JF, Harley CR, Devine JW. (2006) “A comparison of comorbidity measurements to predict health expenditures.” American Journal of Managed Care. 12(2): 110-117.
6. Devine JW, Farley JF, Hadsall RS. (2005) “Patterns and predictors of prescription medication use in the management of headache.” Headache: The Journal of Head and Face Pain. 45(9):1171-1180.
7. Cline RR, Farley JF, Hansen RA, Schommer JC. (2005) “Osteoporosis beliefs and antiresorptive medication use.” Maturitas. 50:196-208.
8. Farley JF, Cline RR, Hansen RA. (2004) “Resorptive drug use patterns among Minnesota females: results of a statewide survey.” American Journal of Health-System Pharmacy. 61:1577-1585.
1. Farley J, Taluja A, Shah B, Varkey A. (2006) Officers detail how postgraduate experience enhances career, profession. Student Pharmacist. 2(2): 28.
2. Farley J, Taluja A, Shah B, Varkey A. (2007) “Where are you going after graduation? Survey on postgraduate training can help your decision process” Student Pharmacist 3(1): 24-25.